On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...
The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
With an expiration date still more than a year away, here's what the latest details reveal.
FDA assigns Prescription Drug User Fee Act (PDUFA) target date of June 29, 2026Ended 2025 with unaudited cash position of $41 ...
PharmaEssentia Announces Updated NCCN Clinical Practice Guidelines Include ropeginterferon alfa-2b-njft (BESREMi®) for ...
The company said that the FDA hold has impacted two experimental gene therapies, RGX-111 and RGX-121. ・REGENXBIO added that ...
Add Yahoo as a preferred source to see more of our stories on Google. The proposal, which was introduced in 2023 and has been paused several times since then, would essentially ban the use of ...
Nutty Peanut Butter Flake Candy with Peanut & Chocolate was voluntarily recalled by the company in December.